Related Experiment Video
Updated: Aug 12, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: July 1, 2013
Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes
B Hofmann1, P Nishanian, T Nguyen
1Center for Interdisciplinary Research in Immunology and Disease, Johnson Comprehensive Cancer Center, University of California, Los Angeles 90024-1747.
Insights
Human immunodeficiency virus (HIV) proteins impair T lymphocyte proliferation by activating the protein kinase A (PKA) pathway. This leads to increased cAMP, biochemical changes, and T cell anergy, hindering immune response.
Area of Science:
- Immunology
- Molecular Biology
- Virology
Background:
- Normal T lymphocyte proliferation is crucial for effective immune responses.
- Human immunodeficiency virus (HIV) infection is known to impair T lymphocyte function.
- The precise mechanisms underlying HIV-induced T cell dysfunction require further elucidation.
Purpose of the Study:
- To investigate the molecular mechanisms by which HIV proteins impair T lymphocyte proliferation.
- To identify key signaling pathways involved in HIV-induced T cell anergy.
- To explore the role of cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA) in this process.
Main Methods:
- Assessed the induction of protein tyrosine kinases and PKA pathway in CD4+ and CD8+ T cells upon HIV protein exposure.
- Measured intracellular cAMP levels in T lymphocytes.
- Utilized agents like cholera toxoid and 8-bromo-cAMP to modulate cAMP/PKA activity.
- Evaluated the activity of protein kinase C (PKC) upon stimulation.
- Tested the effect of cAMP-reducing agents on HIV-induced T cell impairment.
Main Results:
- HIV proteins actively impair T lymphocyte proliferation through induction of protein tyrosine kinases.
- HIV-induced impairment is linked to the activation of the inhibitory PKA pathway, accompanied by increased intracellular cAMP.
- Elevated cAMP/PKA activity leads to biochemical changes that inhibit phytohemagglutinin-stimulated T-lymphocyte proliferation.
- External agents that increase cAMP/PKA activity mimicked HIV's inhibitory effect on proliferation.
- HIV exposure decreased membrane-associated PKC activity, a proliferation promoter.
- Agents reducing cAMP generation restored T-lymphocyte proliferation, neutralizing HIV's effect.
Conclusions:
- HIV-induced augmentation of cAMP/PKA activity is a key mechanism contributing to T lymphocyte anergy.
- This pathway disruption significantly impacts the proliferative capacity of T cells during HIV infection.
- Targeting the cAMP/PKA pathway may offer therapeutic strategies to restore T cell function in HIV-infected individuals.
Abstract:
Proliferation of normal T lymphocytes is impaired by human immunodeficiency virus (HIV) proteins. In this paper, we demonstrate important parts of this mechanism. Initially, HIV-induced impairment of proliferation was shown to be an active process involving induction of protein tyrosine kinases in both CD4 and CD8 T cells. Furthermore, the impairment of cell proliferation was demonstrated to be linked to induction of the inhibitory protein kinase A (PKA) pathway by HIV proteins. This induction of PKA was accompanied by an increase in intracellular cAMP, which is necessary for the activation of PKA. Finally, increases in cAMP/PKA activity were shown to induce biochemical changes that impaired proliferation when cells were stimulated with phytohemagglutinin. This was demonstrated by showing that (i) agents, other than HIV proteins, that increase cAMP/PKA activity (cholera toxoid and 8-bromo-cAMP) also decreased T-lymphocyte proliferation; (ii) exposure of lymphocytes to HIV or cholera toxoid led to decreased membrane activity of the proliferation promoter protein kinase C upon stimulation; and (iii) agents that reduced cAMP generation neutralized the effect of HIV proteins and restored lymphocyte proliferation. These studies show that the HIV-induced augmentation of cAMP/PKA activity may be a key part of the mechanism responsible for all or part of the HIV-induced anergy of T lymphocytes.
Related Concept Videos
Inhibition of Cdk Activity
The JAK-STAT Signaling Pathway
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly

